INOVIO Announces Promising Interim Results From Ongoing Proof-Of-Concept Clinical Trial Of DNA-Encoded Monoclonal Antibodies (Dmabs) For COVID-19
Now in its third year, the trial is led by The Wistar Institute in collaboration with INOVIO, AstraZeneca, and clinical investigators at the University of Pennsylvania. It is funded by the Coronavirus ...
Live Science on MSN19h
Epigenetic 'scars' on the genome can be passed down by grandmothers, study finds
In a story of collaboration and community, researchers identified intergenerational epigenetic changes caused by war and ...
Extreme mutation hotspot in bacteria discovered, with high mutation rates linked to transcriptional activation
A new study published in PLOS Genetics has identified an extreme mutational hotspot within the genome of Pseudomonas ...